Trials / Terminated
TerminatedNCT05730556
A Study of Remote Electrical Neuromodulation for Acute Procedural Pain
Remote Electrical Neuromodulation for Acute Procedural Pain in Chronic Migraine Patients Receiving onabotulinumtoxinA
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the effectiveness of using remote electrical neuromodulation, using the Nerivio ® device, to relieve pain associated with receiving onabotulinumtoxinA (Botox) injections for chronic migraine prevention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Nerivio ® | Non-invasive wearable, remote electrical neuromodulation (REN) device controlled by a smartphone application worn on an armband on the upper arm. |
| DEVICE | Sham | Electrical stimulation to mimic study treatment intervention |
Timeline
- Start date
- 2023-02-13
- Primary completion
- 2024-09-09
- Completion
- 2024-09-09
- First posted
- 2023-02-16
- Last updated
- 2025-10-27
- Results posted
- 2025-10-27
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05730556. Inclusion in this directory is not an endorsement.